BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 22251576)

  • 1. Characterization of a novel tyrosinase inhibitor, (2RS,4R)-2-(2,4-dihydroxyphenyl)thiazolidine-4-carboxylic acid (MHY384).
    Han YK; Park YJ; Ha YM; Park D; Lee JY; Lee N; Yoon JH; Moon HR; Chung HY
    Biochim Biophys Acta; 2012 Apr; 1820(4):542-9. PubMed ID: 22251576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sargaquinoic acid ameliorates hyperpigmentation through cAMP and ERK-mediated downregulation of MITF in α-MSH-stimulated B16F10 cells.
    Azam MS; Kwon M; Choi J; Kim HR
    Biomed Pharmacother; 2018 Aug; 104():582-589. PubMed ID: 29803170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aqueous fraction from Cuscuta japonica seed suppresses melanin synthesis through inhibition of the p38 mitogen-activated protein kinase signaling pathway in B16F10 cells.
    Jang JY; Kim HN; Kim YR; Choi YH; Kim BW; Shin HK; Choi BT
    J Ethnopharmacol; 2012 May; 141(1):338-44. PubMed ID: 22414478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diethylstilbestrol enhances melanogenesis via cAMP-PKA-mediating up-regulation of tyrosinase and MITF in mouse B16 melanoma cells.
    Jian D; Jiang D; Su J; Chen W; Hu X; Kuang Y; Xie H; Li J; Chen X
    Steroids; 2011 Nov; 76(12):1297-304. PubMed ID: 21745488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocatechuic Aldehyde Inhibits α-MSH-Induced Melanogenesis in B16F10 Melanoma Cells via PKA/CREB-Associated MITF Downregulation.
    Ko SC; Lee SH
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel adamantyl benzylbenzamide derivative, AP736, suppresses melanogenesis through the inhibition of cAMP-PKA-CREB-activated microphthalmia-associated transcription factor and tyrosinase expression.
    Lee CS; Jang WH; Park M; Jung K; Baek HS; Joo YH; Park YH; Lim KM
    Exp Dermatol; 2013 Nov; 22(11):762-4. PubMed ID: 24107097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An inhibitory mechanism of action of a novel syringic-acid derivative on α-melanocyte-stimulating hormone (α-MSH)-induced melanogenesis.
    Jeong YJ; Lee JY; Park J; Park SN
    Life Sci; 2017 Dec; 191():52-58. PubMed ID: 28993145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acteoside inhibits melanogenesis in B16F10 cells through ERK activation and tyrosinase down-regulation.
    Son YO; Lee SA; Kim SS; Jang YS; Chun JC; Lee JC
    J Pharm Pharmacol; 2011 Oct; 63(10):1309-19. PubMed ID: 21899547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-melanogenic effect of (Z)-5-(2,4-dihydroxybenzylidene) thiazolidine-2,4-dione, a novel tyrosinase inhibitor.
    Kim SH; Ha YM; Moon KM; Choi YJ; Park YJ; Jeong HO; Chung KW; Lee HJ; Chun P; Moon HR; Chung HY
    Arch Pharm Res; 2013 Oct; 36(10):1189-97. PubMed ID: 23812774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sesamol Inhibited Melanogenesis by Regulating Melanin-Related Signal Transduction in B16F10 Cells.
    Wu PY; You YJ; Liu YJ; Hou CW; Wu CS; Wen KC; Lin CY; Chiang HM
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of α-melanocyte-stimulating hormone-induced melanogenesis and molecular mechanisms by polyphenol-enriched fraction of Tagetes erecta L. flower.
    Sanjaya SS; Park MH; Karunarathne WAHM; Lee KT; Choi YH; Kang CH; Lee MH; Jung MJ; Ryu HW; Kim GY
    Phytomedicine; 2024 Apr; 126():155442. PubMed ID: 38394730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycine hydroxamate inhibits tyrosinase activity and melanin contents through downregulating cAMP/PKA signaling pathways.
    Lin YS; Wu WC; Lin SY; Hou WC
    Amino Acids; 2015 Mar; 47(3):617-25. PubMed ID: 25501504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory Effect of Dried Pomegranate Concentration Powder on Melanogenesis in B16F10 Melanoma Cells; Involvement of p38 and PKA Signaling Pathways.
    Kang SJ; Choi BR; Lee EK; Kim SH; Yi HY; Park HR; Song CH; Lee YJ; Ku SK
    Int J Mol Sci; 2015 Oct; 16(10):24219-42. PubMed ID: 26473849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin suppresses alpha-melanocyte stimulating hormone-stimulated melanogenesis in B16F10 cells.
    Lee JH; Jang JY; Park C; Kim BW; Choi YH; Choi BT
    Int J Mol Med; 2010 Jul; 26(1):101-6. PubMed ID: 20514428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ascorbic acid increases the activity and synthesis of tyrosinase in B16F10 cells through activation of p38 mitogen-activated protein kinase.
    Lee SA; Son YO; Kook SH; Choi KC; Lee JC
    Arch Dermatol Res; 2011 Nov; 303(9):669-78. PubMed ID: 21667118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of piperlonguminine on melanin production in melanoma B16 cell line by downregulation of tyrosinase expression.
    Kim KS; Kim JA; Eom SY; Lee SH; Min KR; Kim Y
    Pigment Cell Res; 2006 Feb; 19(1):90-8. PubMed ID: 16420250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partially purified components of Nardostachys chinensis suppress melanin synthesis through ERK and Akt signaling pathway with cAMP down-regulation in B16F10 cells.
    Jang JY; Kim HN; Kim YR; Choi WY; Choi YH; Shin HK; Choi BT
    J Ethnopharmacol; 2011 Oct; 137(3):1207-14. PubMed ID: 21816215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6-Benzylaminopurine stimulates melanogenesis via cAMP-independent activation of protein kinase A.
    Kim S; Lee J; Jung E; Lee J; Huh S; Hwang H; Kim Y; Park D
    Arch Dermatol Res; 2009 Mar; 301(3):253-8. PubMed ID: 19123006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aglycone of Rh4 inhibits melanin synthesis in B16 melanoma cells: possible involvement of the protein kinase A pathway.
    Jeong YM; Oh WK; Tran TL; Kim WK; Sung SH; Bae K; Lee S; Sung JH
    Biosci Biotechnol Biochem; 2013; 77(1):119-25. PubMed ID: 23291754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of α-MSH and IBMX-induced melanogenesis by cordycepin via inhibition of CREB and MITF, and activation of PI3K/Akt and ERK-dependent mechanisms.
    Jin ML; Park SY; Kim YH; Park G; Son HJ; Lee SJ
    Int J Mol Med; 2012 Jan; 29(1):119-24. PubMed ID: 21972008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.